FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and aims at preventing or treating critical illness polyneuropathy (CIP) and/or critical illness myopathy (CIM). What is presented is a pharmaceutical composition containing a fat emulsion containing at least one triglyceride, wherein one of the residues represents alkanoyl with an odd number of carbon atoms within the range of 5 to 15.
EFFECT: invention provides the effective prevention and treatment of complications associated with intensive therapy ensured by administering the fat emulsion containing fatty acid triglycerides with an odd number of carbon atoms.
10 cl, 1 tbl, 7 ex
Authors
Dates
2014-09-10—Published
2009-11-09—Filed